Literature DB >> 16189092

Increase of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue.

Christian Joukhadar1, Pejman Dehghanyar, Friederike Traunmüller, Robert Sauermann, Bernhard Mayer-Helm, Apostolos Georgopoulos, Markus Müller.   

Abstract

The present study addressed the effect of microcirculatory blood flow on the ability of ciprofloxacin to penetrate soft tissues. Twelve healthy male volunteers were enrolled in an analyst-blinded, clinical pharmacokinetic study. A single intravenous dose of 200 mg of ciprofloxacin was administered over a period of approximately 20 min. The concentrations of ciprofloxacin were measured in plasma and in the warmed and contralateral nonwarmed lower extremities. The microdialysis technique was used for the assessment of unbound ciprofloxacin concentrations in subcutaneous adipose tissue. Microcirculatory blood flow was measured by use of laser Doppler flowmetry. Warming of the extremity resulted in an increase of microcirculatory blood flow by approximately three- to fourfold compared to that at the baseline (P < 0.05) in subcutaneous adipose tissue. The ratio of the maximum concentration (C(max)) of ciprofloxacin for the warmed thigh to the C(max) for the nonwarmed thigh was 2.10 +/- 0.90 (mean +/- standard deviation; P < 0.05). A combined in vivo pharmacokinetic (PK)-in vitro pharmacodynamic (PD) simulation based on tissue concentration data indicated that killing of Pseudomonas aeruginosa (ATCC 27853 and two clinical isolates) was more effective by about 2 log(10) CFU/ml under the warmed conditions than under the nonwarmed conditions (P < 0.05). The improvement of microcirculatory blood flow due to the warming of the extremity was paralleled by an increased ability of ciprofloxacin to penetrate soft tissue. Subsequent PK-PD simulations based on tissue PK data indicated that this increase in tissue penetration was linked to an improved antimicrobial effect at the target site.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189092      PMCID: PMC1251507          DOI: 10.1128/AAC.49.10.4149-4153.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.

Authors:  Pejman Dehghanyar; Cornelia Bürger; Markus Zeitlinger; Florian Islinger; Florian Kovar; Markus Müller; Charlotte Kloft; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

2.  Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease.

Authors:  C Joukhadar; N Klein; M Frossard; E Minar; H Stass; E Lackner; M Herrmann; E Riedmüller; M Müller
Journal:  Clin Pharmacol Ther       Date:  2001-12       Impact factor: 6.875

3.  Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock.

Authors:  C Joukhadar; M Frossard; B X Mayer; M Brunner; N Klein; P Siostrzonek; H G Eichler; M Müller
Journal:  Crit Care Med       Date:  2001-02       Impact factor: 7.598

4.  The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.

Authors:  G M Joynt; J Lipman; C D Gomersall; R J Young; E L Wong; T Gin
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

Review 5.  Microdialysis. A novel tool for clinical studies of anti-infective agents.

Authors:  C Joukhadar; H Derendorf; M Müller
Journal:  Eur J Clin Pharmacol       Date:  2001-06       Impact factor: 2.953

6.  Surgery and intensive care procedures affect the target site distribution of piperacillin.

Authors:  M Brunner; T Pernerstorfer; B X Mayer; H G Eichler; M Müller
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

7.  Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis.

Authors:  Christian Joukhadar; Nikolas Klein; Bernhard X Mayer; Nicole Kreischitz; Georg Delle-Karth; Peter Palkovits; Gottfried Heinz; Markus Müller
Journal:  Crit Care Med       Date:  2002-07       Impact factor: 7.598

8.  Effect of whole-body and local heating on cutaneous vasoconstrictor responses in humans.

Authors:  Thad E Wilson; Jian Cui; Craig G Crandall
Journal:  Auton Neurosci       Date:  2002-05-31       Impact factor: 3.145

9.  Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome.

Authors:  F J Legat; A Maier; P Dittrich; P Zenahlik; T Kern; S Nuhsbaumer; M Frossard; W Salmhofer; H Kerl; M Müller
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  Acetylcholine released from cholinergic nerves contributes to cutaneous vasodilation during heat stress.

Authors:  Manabu Shibasaki; Thad E Wilson; Jian Cui; Craig G Crandall
Journal:  J Appl Physiol (1985)       Date:  2002-08-23
View more
  5 in total

Review 1.  A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.

Authors:  Tony K L Kiang; Urs O Häfeli; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

2.  Current PBPK Models: Are They Predicting Tissue Drug Concentration Correctly?

Authors:  Manuel Ibarra; Marta Vázquez; Pietro Fagiolino
Journal:  Drugs R D       Date:  2020-10-17

Review 3.  Functionalization of Synthetic Bone Substitutes.

Authors:  André Busch; Marcus Jäger; Constantin Mayer; Andrea Sowislok
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

4.  Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study.

Authors:  Kevin Meesters; Reiner Mauel; Evelyn Dhont; Johan Vande Walle; Pauline De Bruyne
Journal:  BMC Infect Dis       Date:  2018-02-23       Impact factor: 3.090

Review 5.  Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time-Kill Approaches.

Authors:  Wisse van Os; Markus Zeitlinger
Journal:  Antibiotics (Basel)       Date:  2021-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.